One-Pot Highly Regioselective Synthesis of Indole-Fused Pyridazino[4,5-b][1,4]benzoxazepin-4(3H)-ones by a Smiles Rearrangement

Xiaolei Jiang; Fangdong Hu

doi:10.1055/s-0037-1609338

Synlett, Table of Contents

Synlett 2018; 29(09): 1207-1210
DOI: 10.1055/s-0037-1609338

letter

One-Pot Highly Regioselective Synthesis of Indole-Fused Pyridazino[4,5-b][1,4]benzoxazepin-4(3H)-ones by a Smiles Rearrangement

Xiaolei Jiang

School of Chemistry and Chemical Engineering, Linyi University, Linyi, Shandong 276005, P. R. of China Email: hufangdong@lyu.edu.cn

,

Fangdong Hu*

School of Chemistry and Chemical Engineering, Linyi University, Linyi, Shandong 276005, P. R. of China Email: hufangdong@lyu.edu.cn

› Author Affiliations

Abstract

All articles of this category

Abstract

A simple and convenient synthesis of indole-fused pyridazino[4,5-b][1,4]benzoxazepin-4(3H)-ones is described. A range of 2-(1H-indol-2-yl)phenols and 4,5-dichloropyridazin-3-ones are compatible with this reaction. A Smiles rearrangement is proposed as a key step in the highly regioselective construction of the products. The easy availability of the starting materials makes this an appealing method in organic synthesis.

Key words

indoles - indolopyridazinobenzoxazepinones - regioselectivity - polycyclic heterocycles - Smiles rearrangement

Full Text

References

References and Notes
1 Hallinan EA. Stapelfeld A. Savage MA. Reichman M. Bioorg. Med. Chem. Lett. 1994; 4: 509
2 Ouyang X. Tamayo N. Kiselyov AS. Tetrahedron 1999; 55: 2827
3 Dols PP. M. A. Folmer BJ. B. Hamersma H. Kuil CW. Lucas H. Ollero L. Rewinkel JB. M. Hermkens PH. H. Bioorg. Med. Chem. Lett. 2008; 18: 1461
4 Dorn A. Schattel V. Laufer S. Bioorg. Med. Chem. Lett. 2010; 20: 3074
5 Gijsen HJ. M. Berthelot D. Zaja M. Brône B. Geuens I. Mercken M. J. Med. Chem. 2010; 53: 7011
6 Binaschi M. Boldetti A. Gianni M. Maggi CA. Gensini M. Bigioni M. Parlani M. Giolitti A. Fratelli M. Valli C. Terao M. Garattini E. ACS Med. Chem. Lett. 2010; 1: 411
7 Lu S.-M. Alper H. J. Am. Chem. Soc. 2005; 127: 14776
8 Liu Y. Chu C. Huang A. Zhan C. Ma Y. Ma C. ACS Comb. Sci. 2011; 13: 547
9 Liu Y. Ma Y. Zhang C. Huang A. Ma C. Synlett 2012; 23: 255
10 Sapegin AV. Kalinin SA. Smirnov AV. Dorogov MV. Krasavin M. Synthesis 2012; 44: 2401
11 Kochanowska-Karamyan AJ. Hamann MT. Chem. Rev. 2010; 110: 4489
12 Li S.-M. Nat. Prod. Rep. 2010; 27: 57
13 Cho S.-D. Park Y.-D. Kim J.-J. Lee S.-G. Ma C. Song S.-Y. Joo W.-H. Falck JR. Shiro M. Shin D.-S. Yoon Y.-J. J. Org. Chem. 2003; 68: 7918
14 Cho S.-D. Song S.-Y. Park Y.-D. Kim J.-J. Joo W.-H. Shiro M. Falck JR. Shin D.-S. Yoon Y.-J. Tetrahedron Lett. 2003; 44: 8995
15 Cho S.-D. Park Y.-D. Kim J.-J. Joo W.-H. Shiro M. Esser L. Falck JR. Ahn C. Shin D.-S. Yoon Y.-J. Tetrahedron 2004; 60: 3763
16 Zuo H. Li Z.-B. Ren F.-K. Falck JR. Meng L. Ahn C. Shin D.-S. Tetrahedron 2008; 64: 9669
17 Zuo H. Meng L. Ghate M. Hwang K.-H. Cho YK. Chandrasekhar S. Reddy CR. Shin D.-S. Tetrahedron Lett. 2008; 49: 3827
18 Zhao Y. Wu Y. Jia J. Zhang D. Ma C. J. Org. Chem. 2012; 77: 8501
19 Zhao Y. Dai Q. Chen Z. Zhang Q. Bai Y. Ma C. ACS Comb. Sci. 2013; 15: 130
20 Yang B. Tan X. Guo R. Chen S. Zhang Z. Chu X. Xie C. Zhang D. Ma C. J. Org. Chem. 2014; 79: 8040
21 Niu X. Yang B. Li Y. Fang S. Huang Z. Xie C. Ma C. Org. Biomol. Chem. 2013; 11: 4102
22 Kitching MO. Hurst TE. Snieckus V. Angew. Chem. Int. Ed. 2012; 51: 2925
23 Zhou Y. Zhu J. Li B. Zhang Y. Feng J. Hall A. Shi J. Zhu W. Org. Lett. 2016; 18: 380
24 Zhan C. Jia J. Yang B. Huang A. Liu Y. Ma C. RSC Adv. 2012; 2: 7506
25 Sang P. Yu M. Tu H. Zou J. Zhang Y. Chem. Commun. 2013; 49: 701
26 CCDC 1581528 contains the supplementary crystallographic data for compound 3n. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.
27 Indolo[1,2-d]pyridazino[4,5-b][1,4]benzoxazepin-9(8H)-ones 3a–r; General Procedure The appropriate 2-(1H-indol-2-yl)phenol 1 (0.30 mmol), 2-tetrahydropyranylpyridazin-3-one 2 (0.30 mmol), and K₂CO₃ (2.5 equiv.) were successively added to a 10 mL Schlenk tube. DMF (2 mL) was then added from a dropper and the resulting solution was stirred at 80 °C for 3 h. The mixture was cooled to r.t. then extracted with EtOAc (×3). The combined organic phase was washed with brine, dried (Na₂SO₄), and filtered. The solvent was then removed in vacuoto give a crude mixture that was purified by column chromatography (silica gel). 8-(Tetrahydro-2H-pyran-2-yl)indolo[1,2-d]pyridazino[4,5-b][1,4]benzoxazepin-9(8H)-one (3a) Light-yellow solid; yield: 104 mg (90%); mp 122–124 °C. ¹H NMR (500 MHz, CDCl₃): δ = 8.43 (s, 1 H), 7.72–7.70 (m, 2 H), 7.66 (d, J = 8.2 Hz, 1 H), 7.54–7.52 (m, 1 H), 7.40–7.27 (m, 4 H), 6.98 (s, 1 H), 6.15–6.13 (m, 1 H), 4.17–4.14 (m, 1 H), 3.81–3.76 (m, 1 H), 2.23–2.15 (m, 1 H), 2.07–2.04 (m, 1 H), 1.80–1.71 (m, 3 H), 1.60–1.58 (m, 1 H). ¹³C NMR (125 MHz, CDCl₃): δ = 157.55, 157.02, 144.65, 136.58, 135.94, 133.09, 131.39, 130.48, 129.45, 129.39, 126.36, 123.99, 123.54, 122.82, 122.15, 121.69, 111.56, 105.97, 83.32, 68.98, 28.99, 24.89, 22.83. HRMS (ESI): m/z [M + H]⁺ calcd for C₂₃H₂₀N₃O₃: 386.1499; found: 386.1491.

Supplementary Material

Supporting Information